首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1674935篇
  免费   128072篇
  国内免费   2979篇
耳鼻咽喉   24419篇
儿科学   46070篇
妇产科学   45269篇
基础医学   240460篇
口腔科学   50863篇
临床医学   146334篇
内科学   322950篇
皮肤病学   34229篇
神经病学   132182篇
特种医学   66578篇
外国民族医学   246篇
外科学   268368篇
综合类   39783篇
现状与发展   3篇
一般理论   475篇
预防医学   121599篇
眼科学   39506篇
药学   128472篇
  3篇
中国医学   3444篇
肿瘤学   94733篇
  2018年   15218篇
  2016年   13255篇
  2015年   15368篇
  2014年   21491篇
  2013年   32095篇
  2012年   43695篇
  2011年   45711篇
  2010年   26923篇
  2009年   25525篇
  2008年   44000篇
  2007年   47005篇
  2006年   47663篇
  2005年   46212篇
  2004年   45085篇
  2003年   43427篇
  2002年   42225篇
  2001年   82911篇
  2000年   85376篇
  1999年   71650篇
  1998年   18693篇
  1997年   16765篇
  1996年   16766篇
  1995年   15754篇
  1994年   14799篇
  1993年   13740篇
  1992年   57347篇
  1991年   55447篇
  1990年   54086篇
  1989年   52653篇
  1988年   48666篇
  1987年   47604篇
  1986年   44711篇
  1985年   43112篇
  1984年   32022篇
  1983年   27289篇
  1982年   15671篇
  1981年   14063篇
  1979年   30563篇
  1978年   21280篇
  1977年   18111篇
  1976年   16187篇
  1975年   17734篇
  1974年   21827篇
  1973年   20790篇
  1972年   19747篇
  1971年   18541篇
  1970年   17676篇
  1969年   17029篇
  1968年   15330篇
  1967年   14043篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
72.
73.
74.
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma  相似文献   
75.
76.
77.
78.

Objective

Arch obstruction after the Norwood procedure is common and contributes to mortality. We determined the prevalence, associated factors, and practice variability of arch reintervention and assessed whether arch reintervention is associated with mortality.

Methods

From 2005 to 2017, 593 neonates in the Congenital Heart Surgeons' Society Critical Left Heart Obstruction cohort underwent a Norwood procedure. Median follow-up was 3.7 years. Multivariable parametric models, including a modulated renewal analysis, were performed.

Results

Of the 593 neonates, 146 (25%) underwent 218 reinterventions for arch obstruction after the Norwood procedure: catheter-based (n = 168) or surgical (n = 50) at a median age of 4.3 months (quartile 1-quartile 3, 2.6-5.7). Interdigitation of the distal aortic anastomosis was protective against arch reintervention. Development of ≥ moderate tricuspid valve regurgitation and right ventricular dysfunction at any point was associated with arch reintervention. Nonsignificant variables for arch reintervention included shunt type and preoperative aortic measurements. Surgical arch reintervention was protective against arch reintervention, but transcatheter reintervention was associated with increased reintervention. Arch reintervention was not associated with increased mortality. There was wide institutional variation in incidence of arch reintervention (range, 0-40 reinterventions per 100 years patient follow-up) and in preintervention gradient (range, 0-64 mm Hg).

Conclusions

Interdigitation of the distal aortic anastomosis during the Norwood procedure decreased the risk of arch reintervention. Surgical arch reintervention is more definitive than transcatheter. Arch reintervention after the Norwood procedure is not associated with increased mortality. Serial surveillance for arch obstruction, integrated with changes in right ventricular function and tricuspid valve regurgitation, is recommended after the Norwood procedure to improve outcomes.  相似文献   
79.
80.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号